TY - JOUR
T1 - EHRA White Paper
T2 - knowledge gaps in arrhythmia management-status 2019
AU - Goette, Andreas
AU - Auricchio, Angelo
AU - Boriani, Giuseppe
AU - Braunschweig, Frieder
AU - Brugada Terradellas, Josep
AU - Burri, Haran
AU - Camm, A. John
AU - Crijns, Harry
AU - Dagres, Nikolaos
AU - Deharo, Jean-Claude
AU - Dobrev, Dobromir
AU - Hatala, Robert
AU - Hindricks, Gerhard
AU - Hohnloser, Stefan H.
AU - Leclercq, Christophe
AU - Lewalter, Thorsten
AU - Lip, Gregory Y. H.
AU - Luis Merino, Jose
AU - Mont, Lluis
AU - Prinzen, Frits
AU - Proclemer, Alessandro
AU - Puererfellner, Helmut
AU - Savelieva, Irina
AU - Schilling, Richard
AU - Steffel, Jan
AU - van Gelder, Isabelle C.
AU - Zeppenfeld, Katja
AU - Zupan, Igor
AU - Heidbuchel, Hein
AU - Boveda, Serge
AU - Defaye, Pascal
AU - Brignole, Michele
AU - Chun, Jongi
AU - Guerra Ramos, Jose M.
AU - Fauchier, Laurent
AU - Svendsen, Jesper Hastrup
AU - Traykov, Vassil B.
AU - Heinzel, Frank R.
AU - ESC Scientific Document Group
N1 - Funding Information:
Conflict of interest: A.G. was funded by research grants from the "Josef-Freitag-Stiftung" and "Deutsche Herzstiftung e.V" and received Speaker fees from Astra Zeneca, Berlin Chemie, Boston Scientific, Boehringer Ingelheim, Bayer Health Care, BMS/Pfizer, Medtronic, Novartis, Daiichi-Sankyo and Omeicos. L.F.(reviewer): Consultant or speaker for Bayer, BMS/Pfizer, Boehringer Ingelheim, Medtronic, Novartis. G.Y.H.L.: Consultant for Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon and Daiichi-Sankyo. Speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. No fees are directly received personally. Information for authors and reviewers are available in Supplementary Material online.
Publisher Copyright:
© 2019 Published on behalf of the European Society of Cardiology. All rights reserved.
PY - 2019/7
Y1 - 2019/7
N2 - Clinicians accept that there are many unknowns when we make diagnostic and therapeutic decisions. Acceptance of uncertainty is essential for the pursuit of the profession: bedside decisions must often be made on the basis of incomplete evidence. Over the years, physicians sometimes even do not realize anymore which the fundamental gaps in our knowledge are. As clinical scientists, however, we have to halt and consider what we do not know yet, and how we can move forward addressing those unknowns. The European Heart Rhythm Association (EHRA) believes that scanning the field of arrhythmia / cardiac electrophysiology to identify knowledge gaps which are not yet the subject of organized research, should be undertaken on a regular basis. Such a review (White Paper) should concentrate on research which is feasible, realistic, and clinically relevant, and should not deal with futuristic aspirations. It fits with the EHRA mission that these White Papers should be shared on a global basis in order to foster collaborative and needed research which will ultimately lead to better care for our patients. The present EHRA White Paper summarizes knowledge gaps in the management of atrial fibrillation, ventricular tachycardia/sudden death and heart failure.
AB - Clinicians accept that there are many unknowns when we make diagnostic and therapeutic decisions. Acceptance of uncertainty is essential for the pursuit of the profession: bedside decisions must often be made on the basis of incomplete evidence. Over the years, physicians sometimes even do not realize anymore which the fundamental gaps in our knowledge are. As clinical scientists, however, we have to halt and consider what we do not know yet, and how we can move forward addressing those unknowns. The European Heart Rhythm Association (EHRA) believes that scanning the field of arrhythmia / cardiac electrophysiology to identify knowledge gaps which are not yet the subject of organized research, should be undertaken on a regular basis. Such a review (White Paper) should concentrate on research which is feasible, realistic, and clinically relevant, and should not deal with futuristic aspirations. It fits with the EHRA mission that these White Papers should be shared on a global basis in order to foster collaborative and needed research which will ultimately lead to better care for our patients. The present EHRA White Paper summarizes knowledge gaps in the management of atrial fibrillation, ventricular tachycardia/sudden death and heart failure.
KW - European Heart Rhythm Association
KW - White Paper
KW - Arrhythmia
KW - Fibrillation
KW - Tachycardia
KW - Heart failure
KW - CARDIAC-RESYNCHRONIZATION THERAPY
KW - IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
KW - PERSISTENT ATRIAL-FIBRILLATION
KW - ATRIOVENTRICULAR NODE ABLATION
KW - EXPERT CONSENSUS STATEMENT
KW - VENTRICULAR-TACHYCARDIA ABLATION
KW - AIAC ITALIAN ASSOCIATION
KW - PULMONARY VEIN ISOLATION
KW - RHYTHM SOCIETY HRS
KW - CATHETER ABLATION
U2 - 10.1093/europace/euz055
DO - 10.1093/europace/euz055
M3 - Article
C2 - 30882143
SN - 1099-5129
VL - 21
SP - 993
EP - 994
JO - EP Europace
JF - EP Europace
IS - 7
ER -